Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Melanoma

  Free Subscription


18.12.2017

1 Ann Surg Oncol
1 Br J Cancer
1 Br J Dermatol
1 Cancer Res
1 Clin Cancer Res
1 Curr Opin Oncol
1 Int J Cancer
5 J Am Acad Dermatol
1 J Cell Physiol
1 J Clin Invest
1 J Clin Oncol
1 J Invest Dermatol
2 J Surg Oncol
3 Melanoma Res
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. WONG SL, Faries MB, Kennedy EB, Agarwala SS, et al
    Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Ann Surg Oncol. 2017 Dec 13. pii: 10.1245/s10434-017-6267.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. WU CE, Esfandiari A, Ho YH, Wang N, et al
    Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    Br J Cancer. 2017 Dec 12. pii: bjc2017433. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Dermatol

  3. OLSEN CM, Wilson LF, Green AC, Biswas N, et al
    How many melanomas might be prevented if more people applied sunscreen regularly?
    Br J Dermatol. 2017 Dec 14. doi: 10.1111/bjd.16079.
    PubMed     Text format     Abstract available


    Cancer Res

  4. DIAZ-MARTINEZ M, Benito-Jardon L, Alonso L, Koetz-Ploch L, et al
    miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-1318.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. JIN Y, Zhang P, Wang Y, Jin B, et al
    Neddylation blockade diminishes hepatic metastasis by dampening cancer stem-like cells and angiogenesis in uveal melanoma.
    Clin Cancer Res. 2017 Dec 12. pii: 1078-0432.CCR-17-1703.
    PubMed     Text format     Abstract available


    Curr Opin Oncol

  6. CHENG PF
    Medical bioinformatics in melanoma.
    Curr Opin Oncol. 2017 Dec 8. doi: 10.1097/CCO.0000000000000428.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. MARTIN CA, Cullinane C, Kirby L, Abuhammad S, et al
    Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31220.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  8. TRIPATHI SV, Morris CR, Alhamad T, Fields RC, et al
    Metastatic melanoma after solid organ transplantation: An interdisciplinary, institution-based review of management with systemic and targeted therapies.
    J Am Acad Dermatol. 2018;78:184-185.
    PubMed     Text format    

  9. MOON HR, Kang HJ, Won CH, Chang SE, et al
    Heterogeneous spectrum of acral melanoma: A clinicoprognostic study of 213 acral melanomas according to tumor site.
    J Am Acad Dermatol. 2018;78:179-182.
    PubMed     Text format    

  10. WILSON JM, Rodriguez E, Kelly BC
    Retrospective effects of the American Joint Committee on Cancer's eighth edition guidelines for staging melanoma.
    J Am Acad Dermatol. 2018;78:177-178.
    PubMed     Text format    

  11. KURTZMAN DJ, Vleugels RA
    Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features.
    J Am Acad Dermatol. 2017 Dec 8. pii: S0190-9622(17)32764.
    PubMed     Text format     Abstract available

  12. ILYAS M, Costello CM, Zhang N, Sharma A, et al
    The role of the ugly duckling sign in patient education.
    J Am Acad Dermatol. 2017;77:1088-1095.
    PubMed     Text format     Abstract available


    J Cell Physiol

  13. ROSS CL, Kaushik S, Valdes-Rodriguez R, Anvekar R, et al
    MicroRNAs in Cutaneous Melanoma: Role as Diagnostic and Prognostic Biomarkers.
    J Cell Physiol. 2017 Dec 11. doi: 10.1002/jcp.26395.
    PubMed     Text format     Abstract available


    J Clin Invest

  14. TAMIYA H, Kim H, Klymenko O, Kim H, et al
    SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.
    J Clin Invest. 2017 Dec 11. pii: 95410. doi: 10.1172/JCI95410.
    PubMed     Text format     Abstract available


    J Clin Oncol

  15. WONG SL, Faries MB, Kennedy EB, Agarwala SS, et al
    Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    J Clin Oncol. 2017 Dec 12:JCO2017757724. doi: 10.1200/JCO.2017.75.7724.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  16. CONIC RZ, Arbesman J
    Melanoma Tumor Characteristics: An Analysis of Mutational Burden and Copy Number Alterations by Patient Age and Stage.
    J Invest Dermatol. 2017 Dec 5. pii: S0022-202X(17)33236.
    PubMed     Text format    


    J Surg Oncol

  17. LOOK HONG NJ, Cheng SY, Baxter NN, Wright FC, et al
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24936.
    PubMed     Text format     Abstract available

  18. JAKUB JW, Racz JM, Hieken TJ, Gonzalez AB, et al
    Neoadjuvant systemic therapy for regionally advanced melanoma.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24939.
    PubMed     Text format     Abstract available


    Melanoma Res

  19. SEREMET T, Planken S, Schreuer M, Jansen Y, et al
    Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.
    Melanoma Res. 2017 Dec 8. doi: 10.1097/CMR.0000000000000415.
    PubMed     Text format     Abstract available

  20. BISSCHOP C, Ter Elst A, Bosman LJ, Platteel I, et al
    Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.
    Melanoma Res. 2017 Dec 11. doi: 10.1097/CMR.0000000000000421.
    PubMed     Text format     Abstract available

  21. GALLO S, Coha V, Caravelli D, Becco P, et al
    BRAF-inhibitors can exert control of disease in BRAF T599I mutated melanoma: a case report.
    Melanoma Res. 2017 Dec 11. doi: 10.1097/CMR.0000000000000417.
    PubMed     Text format     Abstract available


    PLoS One

  22. XU H, Gong J, Liu H
    High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
    PLoS One. 2017;12:e0189675.
    PubMed     Text format     Abstract available

  23. REIMER M, Denby E, Zustiak SP, Schober JM, et al
    Ras GAP-related and C-terminal domain-dependent localization and tumorigenic activities of IQGAP1 in melanoma cells.
    PLoS One. 2017;12:e0189589.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  24. SU Y, Wei W, Robert L, Xue M, et al
    Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1712064115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: